Research use only

Third-party testing

Test results

A sample from every batch we sell is sent to an independent lab for identity confirmation, mass quantification, and purity analysis by LC-MS/MS. Click a Certificate of Authenticity (COA) below to view the full report as received from the testing laboratory.

Retatrutide - Certificate of Analysis COA-2026-SC-00036

SideChain Analytics · Sample RET-019 · Issued June 16, 2026

Compound
Retatrutide
CAS
2381089-83-2
Formula
C229H366N50O75
Mol. weight
4734.4 g/mol
Total mass
53.0 mg
Appearance
Lyophilized powder
Received
June 12, 2026
Analyzed
June 16, 2026

Analytical results

TestSpecificationResultStatus
IdentityRetatrutideRetatrutide confirmedPASS
Quantity10.00 mg10.29 mgPASS
Purity≥ 98%99.93%PASS

Method & chromatogram

Qualitative and quantitative analysis by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Method B: Agilent 1290 Infinity II + 6495 QQQ (ESI+). Column: Agilent Poroshell 120 EC-C18, 2.1×100 mm, 2.7 µm. Solvent A: 0.1% formic acid in H₂O; Solvent B: 0.1% formic acid in acetonitrile. Precursor ion [M+5H]⁵⁺ at 947.90 Da.

Quantifier (MRM) · 947.9 › 136.1 · CE 30 V — Qualifier (MRM) · 947.9 › 110.1 · CE 35 V

LC-MS/MS chromatogram (MRM response vs. retention time in minutes) shows a single dominant retatrutide peak at RT 6.36 min with no significant impurity peaks.

Research use only — this report documents analytical results only and is not a drug-release or quality certification.